Mereo BioPharma Group plc

NasdaqCM:MREO 주식 보고서

시가총액: US$635.9m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Mereo BioPharma Group 소유권

주요 주주는 누구이며 내부자가 매수 또는 매도한 적이 있나요?

최근 내부자 거래

NasdaqCM:MREO 회사 또는 개인의 최근 내부자 거래
날짜가치이름엔티티역할공유최대 가격
13 Sep 24SellUS$121,693Christine FoxIndividual28,286US$4.47
13 Sep 24SellUS$133,051Charles SermonIndividual30,926US$4.47
13 Sep 24SellUS$69,477John LewickiIndividual16,149US$4.47
13 Sep 24SellUS$381,423Denise Scots-KnightIndividual88,657US$4.47
13 Sep 24SellUS$637,203Alexandra Hughes-WilsonIndividual148,110US$4.47
26 Jun 24SellUS$115,369Alexandra Hughes-WilsonIndividual33,102US$3.69
26 Jun 24SellUS$463,487Denise Scots-KnightIndividual132,985US$3.69
26 Jun 24SellUS$147,876Christine FoxIndividual42,429US$3.69
26 Jun 24SellUS$84,427John LewickiIndividual24,224US$3.69
26 Jun 24SellUS$161,678Charles SermonIndividual46,389US$3.69
17 Nov 23BuyUS$984,120Rubric Capital Management LPCompany475,666US$2.08
13 Nov 23BuyUS$2,966Rubric Capital Management LPCompany1,440US$2.06
10 Nov 23BuyUS$720,643Rubric Capital Management LPCompany351,639US$2.06
07 Nov 23BuyUS$899,742Rubric Capital Management LPCompany437,724US$2.06
01 Nov 23BuyUS$284,678Rubric Capital Management LPCompany144,426US$1.98
30 Oct 23BuyUS$775,787Rubric Capital Management LPCompany433,695US$1.81

내부자 거래량

내부자 구매: MREO insiders는 지난 3개월 동안 주식만 판매했습니다.

소유권 분석

MREO 의 소유 구조는 어떻게 되나요?
소유자 유형공유 수소유권 비율
개인 내부자5,143,7033.35%
일반 대중40,513,62526.4%
헤지 펀드51,525,04233.5%
교육기관56,422,69736.7%

주식의 희석: 지난 해 주주 수는 희석되었으며, 총 발행 주식 수 22.3% 만큼 증가했습니다.

최대 주주

상위 25 주주가 회사의 69.69%를 소유하고 있습니다.
소유권이름공유현재 값변경 %포트폴리오 %
14.1%
Rubric Capital Management LP
21,697,347US$89.8m-35.2%1.39%
7.68%
Adage Capital Management, L.P.
11,791,310US$48.8m26.4%0.09%
6.04%
Rock Springs Capital Management LP
9,283,492US$38.4m14%1.12%
5.7%
Mangrove Partners IM, LLC
8,752,893US$36.2m0%2.94%
5.17%
Janus Henderson Group plc
7,945,704US$32.9m0.82%0.01%
4.37%
Deerfield Management Company, L.P. Series C
6,710,429US$27.8m0%0.42%
3.26%
683 Capital Management, LLC
5,000,000US$20.7m-13%1.97%
3.06%
Alkeon Capital Management, LLC
4,698,100US$19.5m10.9%0.13%
2.87%
Frazier Life Sciences Management, LP
4,401,371US$18.2m0%0.75%
2.17%
Clearline Capital LP
3,326,718US$13.8m0%1.14%
2.08%
Millennium Management LLC
3,201,705US$13.3m46.9%0.01%
1.92%
Denise Scots-Knight
2,942,410US$12.2m3.5%데이터 없음
1.7%
Tejara Capital Limited., Asset Management Arm
2,615,458US$10.8m5.88%3.98%
1.63%
Goldman Sachs Group, Investment Banking and Securities Investments
2,507,513US$10.4m11.8%데이터 없음
1.16%
Integral Health Asset Management, LLC
1,775,000US$7.3m86.8%0.69%
1.15%
Renaissance Technologies LLC
1,762,003US$7.3m5.36%0.01%
0.82%
Perceptive Advisors LLC
1,253,250US$5.2m0%0.11%
0.81%
Soleus Capital Management, L.P.
1,246,953US$5.2m-52.4%0.41%
0.74%
Marshall Wace LLP
1,144,051US$4.7m0%0.01%
0.62%
Nationwide Fund Advisors
959,467US$4.0m53.9%0.03%
0.58%
CHI Advisors LLC
897,809US$3.7m0%1.33%
0.58%
Charles Sermon
893,041US$3.7m4.04%데이터 없음
0.55%
Susquehanna International Group, LLP, Asset Management Arm
840,264US$3.5m-48.1%0.01%
0.47%
Tema Global Limited, Asset Management Arm
722,102US$3.0m38.4%2.03%
0.44%
Acuta Capital Partners, LLC
677,000US$2.8m70.2%2.03%